Illustrative image – not actual.Bangalore-based Biocon is planning to set up a vaccine bio-pharma manufacturing plant in Andhra Pradesh. The project to be implemented in phases will entail an investment of Rs.1,000 crore.
While the manufacturing facility (Phase I) will be located in 50 acres of land at Jawahar Pharma City, a pharma special economic zone near Visakhapatnam, the R&D facility will be set up in the phase three biotech park near Hyderabad.
The company is in the process of acquiring 10 acres of land for the research facility in the biotech park, which is being developed by the Andhra Pradesh Industrial Infrastructure Corporation.
